Jove
Visualize
Contact Us

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

4.2K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Bmp Signaling Is A Prognostic Marker In Patients With Colorectal Cancer And Associates With Frailty.
  1. Home
  2. Bmp Signaling Is A Prognostic Marker In Patients With Colorectal Cancer And Associates With Frailty.

Related Experiment Video

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.5K

BMP Signaling Is a Prognostic Marker in Patients With Colorectal Cancer and Associates With Frailty.

Shohei Sawata1, Shota Shimizu1, Yoshiaki Matsumi2

  • 1Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Japan.

Cancer Diagnosis & Prognosis
|July 4, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

High bone morphogenetic protein-4 (BMP-4) expression in colorectal cancer (CRC) patients indicates a poorer prognosis and is linked to inflammation and poor nutrition. This finding offers new insights into CRC progression and patient outcomes.

Keywords:
BMP-4Colorectal cancerprognosis

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

248
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

505

Related Experiment Videos

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

248
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

505

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Bone morphogenetic proteins (BMPs) are crucial in the transforming growth factor-β superfamily, influencing colorectal cancer (CRC) progression.
  • Targeting BMPs for CRC treatment is complex due to their roles in inflammation and nutrition.
  • BMP-4 is implicated in CRC, necessitating an evaluation of its prognostic significance.

Purpose of the Study:

  • To assess the prognostic value of BMP-4 expression in colorectal cancer (CRC) patients.
  • To investigate the correlation between BMP-4 levels and the inflammatory and nutritional status of CRC patients.

Main Methods:

  • Immunohistochemistry was used to analyze BMP-4 expression in tumor tissues from 144 CRC patients.
  • Kaplan-Meier and multivariate analyses were employed to evaluate the relationship between BMP-4 levels and clinical outcomes.

Main Results:

  • High BMP-4 expression correlated with significantly shorter overall survival in CRC patients.
  • BMP-4 was identified as an independent prognostic factor for overall survival and non-CRC-related mortality.
  • Elevated BMP-4 levels were associated with a high C-reactive protein/Albumin ratio, sarcopenia, and osteopenia.

Conclusions:

  • BMP-4 serves as a significant prognostic biomarker in colorectal cancer.
  • BMP-4 expression is linked to inflammatory markers and nutritional deficits in CRC patients.
  • BMP-4 may predict mortality from causes other than colorectal cancer itself.